Research Type: Extramural
Professor Baker and his team aim to develop a new blood-based test to detect bowel cancer in its early stages.
Dr Wilmott and his team are focused on finding treatments for the more than 40% of patients that are not cured with our best current therapies.
This project will focus on developing adaptive radiotherapy for locally advanced lung, prostate and oligometastatic cancer.
This project will lay the foundations for possible clinical trials of drugs targeting the ELF5 protein as a way of preventing hormone therapy resistance in breast cancer.
Dr Wong’s research is focused on the chemical changes in DNA and RNA that are associated with acute myeloid leukaemia.
This project aims to develop a way to increase the effectiveness of chemotherapy in pancreatic cancer using a dual treatment approach that targets the production of protective tissue in the tumour.
Dr Debbie Watson will develop a potential new treatment strategy using manipulated stem cell transplantation combined with drugs that block development of graft-versus-host disease.
Professor Maija Kohonen-Corish and her team have been developing crucial evidence on MCC protein alteration with the aim of creating new treatment targets and biomarkers for bowel cancer.
Dr Micklethwaite and his team aim to create a new class of CAR T-cells that are capable of recognising and attacking acute myeloid leukaemia cells with a high degree of accuracy.
This is one of the first studies in Australia and the world looking at the role of gut bacteria in lung cancer development and progression.